These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


711 related items for PubMed ID: 26132312

  • 1. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE, Meltzer EO.
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [Abstract] [Full Text] [Related]

  • 2. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 3. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A.
    Int Arch Allergy Immunol; 2021 Apr 24; 182(11):1026-1035. PubMed ID: 34082425
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 Apr 24; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 5. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
    Debbaneh PM, Bareiss AK, Wise SK, McCoul ED.
    Otolaryngol Head Neck Surg; 2019 Sep 24; 161(3):412-418. PubMed ID: 30961435
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.
    Pediatr Allergy Immunol; 2016 Mar 24; 27(2):126-33. PubMed ID: 26928753
    [Abstract] [Full Text] [Related]

  • 7. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
    Bousquet J, Meltzer EO, Couroux P, Koltun A, Kopietz F, Munzel U, Kuhl HC, Nguyen DT, Salapatek AM, Price D.
    J Allergy Clin Immunol Pract; 2018 Mar 24; 6(5):1726-1732.e6. PubMed ID: 29425904
    [Abstract] [Full Text] [Related]

  • 8. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W.
    Allergy Asthma Proc; 2012 Mar 24; 33(4):324-32. PubMed ID: 22856633
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z, Xun Y, Shi X, Guan B, Wang M.
    Eur Arch Otorhinolaryngol; 2022 May 24; 279(5):2457-2464. PubMed ID: 34415405
    [Abstract] [Full Text] [Related]

  • 10. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr 24; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 11. Azelastine and fluticasone nasal spray: any advantage?
    Drug Ther Bull; 2014 Feb 24; 52(2):21-4. PubMed ID: 24504481
    [Abstract] [Full Text] [Related]

  • 12. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 24; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 13. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Int Arch Allergy Immunol; 2020 Dec 24; 181(10):754-764. PubMed ID: 32829329
    [Abstract] [Full Text] [Related]

  • 14. Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis.
    Sousa-Pinto B, Vieira RJ, Brozek J, Cardoso-Fernandes A, Lourenço-Silva N, Ferreira-da-Silva R, Ferreira A, Gil-Mata S, Bedbrook A, Klimek L, Fonseca JA, Zuberbier T, Schünemann HJ, Bousquet J.
    J Allergy Clin Immunol; 2024 Aug 24; 154(2):340-354. PubMed ID: 38685482
    [Abstract] [Full Text] [Related]

  • 15. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C.
    Rhinology; 2018 Mar 01; 56(1):33-41. PubMed ID: 28942457
    [Abstract] [Full Text] [Related]

  • 16. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD.
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep 01; 7(3):223-8. PubMed ID: 23862774
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L, Demoly P, Price D.
    Expert Rev Clin Pharmacol; 2016 Sep 01; 9(5):705-14. PubMed ID: 26839083
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan 01; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 19. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
    Meltzer EO, Bachert C, Mayer MJ, Kopietz F, Koltun A, Maus J, D'Addio AD.
    Allergy Asthma Proc; 2020 Jul 01; 41(4):265-270. PubMed ID: 32393418
    [Abstract] [Full Text] [Related]

  • 20. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R.
    J Manag Care Spec Pharm; 2016 Dec 01; 22(12):1426-1436. PubMed ID: 27882840
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.